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Objective: To investigate the function and morphology of endothelial ceil (EC) seeded grafts. 
Design: Experimental open study. 
Chief outcome measures: Endoluminal release of prostacyclin (6-Keto-PGFI~) and thromboxane B2 (TxB2), patency, EC 
coverage and cell identity. 
Materials: In 12 sheep, segments of both carotid arteries were excised. On one side a seeded and on the other an unseeded 
dacron graft were inserted. After 3 months the grafts were excised, hz grafts and arteries, the endoluminal release of 6-keto- 
PGFla and TxB2 was determined in a perfusion system. Scanning electron microscopy (SEM) and light microscopy were 
used to determine the EC coverage and cell identity. 
Results: Eight animals urvived. Three seeded and two unseeded grafts were occluded. Prostacyclin release did not differ 
significantly between seeded and unseeded grafts and arteries, when the arteries were looked upon as one group. When the 
graft was compared with its corresponding artery, i.e. the artery it replaced, a significantly lower release was found in the 
unseeded group. Thromboxane release was undetectable in arteries but significantly higher in both graft groups. SEM 
revealed a cellular coverage of 75% in the seeded grafts and 50% in the unseeded (not significant). Light microscopy showed 
a patchy staining for Factor VIII-related antigen in some grafts in both groups. 
Conclusion: Prostacyclin release in unseeded and seeded acron grafts did not differ 3 months after implantation i sheep, 
except when the ~raft was compared with its corresponding artery. The significance of this remains to be settled. Seeded 
grafts did not have a higher proportion of endothelial coverage than unseeded grafts. 
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Introduction 
The ability of prosthetic vascular grafts to maintain 
patency is inferior to that of the native artery and vein 
grafts. This may depend on the fact that the prosthetic 
vascular graft does not heal with a true endothelial 
cell fining. The concept of endothelial cell-seeding was 
introduced in an attempt o create an intimal lining 
which has properties similar to that of the native 
artery. Canine experiments have shown that seeded 
endothelial cells produce an intimal ining in the graft 
and that such grafts have a better patency than 
unseeded 1 grafts. One difficulty in evaluating this 
process lies in the fact that there are species differences 
in the healing of synthetic grafts. Another difficulty is 
the lack of functional "tests" of the healed graft. 
The endothelial cell is involved in the healing 
process of a traumatised artery. 2 It also produces a 
*Please address all correspondence to: Norman Jensen, Department 
of Surgery, Centralsjukhuset, S-651 85 Karlstad, Sweden 
large number of active substances which act or 
interact with others to keep the vessel wall free from 
blood clot. 3'4 One of these substances i prostacycfin 
(PGI2) which is a potent inhibitor of platelet aggrega- 
tion. The new intima in grafts, either seeded or 
unseeded, produces PGI2 in small amounts. These 
measurements have usually been made from punch 
biopsies 5 or after luminal incubation. 6 Another tech- 
nique is to use an artificial circulation with physio- 
logical flows and pressures to give a better approxima- 
tion of the in vivo situation. This also increases PGI 2 
release because of the presence of shear stress. In 
addition, the perfusion system only communicates 
with the luminal area and not with the deeper layers 
of the graft tube. 7-1° Production of PGI 2 could possibly 
contribute to decreased thrombogenicit)~ whereas a 
high thromboxane (TxA2) release could have the 
opposite effect. In a previous experiment we have 
showed that, after 3 weeks, seeded grafts in sheep had 
a significantly higher release of PGI2 than unseeded, 
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although they did not reach the levels of the native 
artery. ~a The present experiment was designed to 
investigate the capacity of the seeded and unseeded 
grafts to produce prostacyclin after 3 months of 
implantation and to compare this with that of the 
native artery. As there was a significant difference after 
3 weeks of implantation the 3 month time span was 
used to evaluate whether the differences at 3 weeks 
were further enhanced or not. 
Material and Methods 
Twelve male sheep weighing 25-34 kg were used and 
cared for according to the European Convention on 
Animal Care. The experiment was approved by the 
Animal Ethics Committee of Lund University. 
Surgical procedure 
The animals were anaesthetised with approximately 
200 mg of thipental-sodium (Pentotal, Abbott Labora- 
tories in North Chicago, Illinois, U.S.A.), intubated 
and ventilated with an oxygen/N20 mixture. Anaes- 
thesia was maintained with a continuous infusion of 
ketamin hydrochloride (Ketalar, Park-Davis, Morris 
Plains, New Jerse~ U.S.A.) approximately 240 mg per 
hour combined with 10-20 mg diazepam (Apozepam, 
A/S Apothekernes Laboratorier, Oslo, Norway). Dur- 
ing the operation the animal received 500 ml Ringer's 
solution. Antibiotics (Combiotic Vet containing dihy- 
drostreptomycin: 250 mg/ml, benzylpenicillin: 200 
mg/ml, and procaine hydrochloride: 20 mg/ml; 
Pfizer, New York, U.S.A.) were given in a dose of 3 ml 
once a day for 4 days, the first dose being given 
preoperatively. 
A midline neck incision was made and the left 
jugular vein excised for endothelial cell harvest (see 
below). Both carotid arteries were dissected free and 
the tributaries ligated. Before clamping, 100 IU of 
heparin (Kabi Pharmacia AB, Stockholm, Sweden) per 
kg body weight was given. About 5 cm of the artery 
was excised. A 6 cm long and 6 mm diameter 
externally reinforced knitted double velour dacron 
graft (Microvel supported 100, Meadox Medicals, 
Oakland, New Jersey, U.S.A.) was inserted on each 
side using oblique anastomoses. On one side a 
preclotted and on the other a preclotted and endothe- 
lial cell-seeded graft were inserted. The side was 
chosen at random just before insertion. After 3 months 
the animals were anaesthetised and the grafts were 
dissected free, patency assessed, excised and then 
perfused as described below. 
Preparation of endothelial cells 
After careful dissection with ligation of all tributaries, 
8-12 cm of the left jugular vein was excised arid small 
cannulae (Gam.bro Lundia AB, Lund, Sweden) were 
introduced and tied at each end. The vein was flushed 
with phosphate-buffered saline (PBS, Nordvac Med- 
ica) and then filled with a solution of Dispase (Dispase 
II, neutral protease, Boehringer Mannheim, Man- 
nheim, German55 catalogue no. 165859) 5 mg/ml in 
PBS and incubated at 37°C for 60 min. The vein was 
emptied of the enzyme solution, filled with PBS and 
slightly massaged between fingers to loosen any 
residual cells. Both cell suspensions were centrifuged 
at 200 g for 7 min, the pellets were then washed in PBS 
in the same manner, suspended in 1 ml M-199 
(Medium 199, Gibco Laboratories, Grand Island, New 
York, U.S.A.) and an aliquot counted in a Bfirker 
chamber and viability assessed with trypan blue. One 
of the two preclotted grafts was occluded at one end 
with a clamp, filled with the cell suspension, topped 
up with M-199, and occluded at the other end. It was 
left for 45 min at 37°C to allow the cells to adhere and 
during this time it was rotated by 90 ° every 10 min. In 
order not to diminish the number of cells seeded, no 
subculturing was made. Cells harvested in an identi- 
cal manner have been cultured and identified as 
endothelial cells by their expression of Factor VIII- 
related antigen. 
Evaluation of prostacyclin and thromboxane r lease 
The excised carotid arteries, as well as the grafts, were 
perfused with Hank's balanced salt solution (Gibco 
Laboratories, pH 7.4, 290 mOsm) in an ex vivo 
perfusion system at a pressure of 100 mm Hg, and a 
pulsatile flow of 100 ml/min for five 15 min periods. 
For the last period arachidonic acid (AA) was added 
(4 ~tg/ml). This method has previously been described 
in detail. 12'13 The perfusate from each period was 
frozen at -20°C and later assessed for prostacyclin and 
thromboxane content. Prostacyclin was determined as 
the stable degradation product 6-keto-PGFl~ using a 
radio-immunoassay kit (Amersham International, 
Amersham, U.K.) and expressed as pg /mm 2of lumi- 
nal surface/15 min. The cross-reactivity for other 
prostaglandins with this kit is less than 1%. Throm- 
boxane A2 was determined as its stable degradation 
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product thromboxane B2 using radioimmunoassay 
(Amersham International, Amersham, U.K.). Release 
is expressed as pg/mm 2 of luminal surface/15 min. 
All samples were run in duplicates in one assay. 
both because of graft infection  one side. Among the 
other eight animals there were three occlusions of 
seeded grafts and two occlusions of unseeded grafts. 
One animal had occlusion on both sides, the other 
occlusions were unilateral. 
Histological examination 
After perfusion the arteries and the graft specimens 
were perfusion-fixed with 2.5% glutaraldehyde in 0.1 
M cacodylate buffer at 100 mm Hg to minimise 
distortion. The graft was divided in four parts and 
alternately allocated to light or scanning electron- 
microscopic examination (SEM). 
Grafts were studied with haematoxylin-eosin stain- 
ing, and a polyclonal rabbit anti-human antibody at a 
dilution of 1/100 (Dakopatts, Copenhagen, Denmark, 
code No. A 082) was used to stain for FVIII-related 
antigen. The antibody was then visualised through an 
alkaline phosphatase anti-alkaline phosphatase 
(APAAP) complex (Dakopatts No. D651). The anti- 
body reacts with sheep Factor VIII-related antigen as 
shown in the sheep artery. For SEM, after perfusion 
fixation, the specimens were dehydrated in ethanol, 
incubated for 10 min in hexamethyld!silazane 
(HMDS), dried in air and sputter-coated with gold- 
palladium. 14 The specimens were evaluated without 
knowing whether the graft was seeded or not. From 
each graft five different areas were investigated. 
Endothelial cell tufts and cobble stone morphology 
were used as identification criteria for endothelium, 
and cell coverage was assessed as a percentage of the 
area seen at 150 × magnification. 
Statistics 
Results of prostanoid and thromboxane analysis are 
expressed as pg/mm 2 of graft luminal area/15 min 
and are presented as medians and quartiles. For 
comparison, the Wilcoxon signed rank test was used. 
Results 
A median of 200 × 103 cells (range 100-800 × 103) 
were harvested. The viability exceeded 95%. Four 
animals did not survive the 3 month period. Two 
animals died after the operation - -  one because of 
severe diarrhoea nd the other because of aspiration. 
The other two died after 21 and 37 days, respectively, 
Prostacyclin and thromboxane r lease 
When both graft groups were compared with the 
artery group, prostacyclin release did not differ 
significantly between seeded and unseeded grafts, 
and there was no difference between any of the graft 
groups and the arterial group (Fig. 1). When compared 
to their corresponding arteries, i.e. the artery they 
replaced, prostacyclin release was similar in the 
seeded group (Fig. 2). The unseeded grafts had similar 
release during the first three perfusion periods, but 
significantly lower during the last two periods 
(p = 0.02; fig. 3). 
The release of thromboxane from native artery was 
extremely low, and it did not respond to addition of 
arachidonic acid, which was seen in the two graft 
groups (Fig. 4). At 75 min, both grafts differed 
significantly (p= 0.005) from native artery but not from 
each other. 
Histology 
The pseudointima v ried in thickness, but was mostly 
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Fig. 1. Release of 6-keto-PGFl~ from native artery, seeded graft and 
unseeded graft, perfused exvivo for five 15 min periods. AA = addi- 
tion of arachidonic a id. Median and quartiles. ([3) artery; (~N) 
seeded graft; (m) unseeded graft. 
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Fig. 2. Release of 6-keto-PGFi~ from seeded graft and its corre- 
sponding artery, i.e. the artery it replaced. Perfused ex vivo for five 
15 min. periods. AA = addition of arachidonic acid. Median and 
quartiles. ([~) corresponding artery; ([]) seeded graft. 
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Fig. 4. Release of TxB2 from native artery, seeded graft and 
unseeded graft perfused ex vivo for five 15 min. periods. AA = addi- 
tion of arachidonic acid. Median and quartiles. ([3) artery; (R) 
seeded graft; (ll) unseeded graft. 
thin. Two of the seeded grafts, and three of the 
unseeded grafts showed a posit ive staining for Factor 
VI I I -related antigen, but  only in patches, a l though 
there could be a seemingly  cont inuous cellular layer 
on the luminal  side of the wall. SEM revealed 
endothel ia l  cells (Fig. 5) in all grafts, but  not neces- 
sari ly in all five evaluated areas of each graft. There 
were also cells with characteristics of smooth  muscle 
cells or f ibroblasts (Fig. 6). The cellular coverage was  a 
med ian  of 75% (range 40-80) among the seeded grafts 
and among the unseeded grafts 50% (30-63; Ns). 
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Fig. 3. Release of 6-keto-PGF~ from unseeded graft and its 
corresponding artery, i.e. the artery it replaced. Perfusion ex vivo for 
five 15 min. periods. AA = addition of arachidonic acid. Median 
and quartiles. ([~) corresponding artery; (ll) unseeded graft. 
Control  nat ive arteries showed a 90-100% coverage of 
the luminal  surface by  endothel ial  cells. 
Discussion 
Prostacycl in is a potent  inhibitor of platelet aggrega- 
tion. The product ion of PGt 2 might  therefore be of 
benefit  and show the functional qual ity of grafts in 
contrast to morpholog ica l  methods.  We have pre- 
v ious ly  shown that the prostacycl in product ion in 
seeded grafts is signif icantly higher than in unseeded 
11 after 3 weeks  of implantat ion.  The present experi- 
ment  with grafts imp lanted  for 3 months  reveals that 
Fig. 5. SEM picture of endothelial cell-covered luminal surface. 
Original magnification × 655. Reproduced here at 50%. 
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Fig. 6. SEM picture of smooth muscle ell-covered luminal surface. 
Original magnification × 655. Reproduced here at 50%. 
the seeded grafts increased their ability to release 
prostacyclin to levels similar to those of the native 
artery. The unseeded grafts, which had almost no 
release at 3 weeks, also attained this ability after 3 
months with no difference vs. seeded grafts, neither in 
basal release, nor in response to addition of arachi- 
donic acid. Greisler et aI. 1~ found that the release of 
PGI 2 from an unseeded polyglactin graft in the rabbit 
reached aortic levels of release in 3 months. In this 
respect sheep and rabbits eem comparable. In rabbits 
subjected to balloon dilatation injury, the endothelium 
is destroyed. After 3 weeks the pseudointima is
capable of releasing prostacyclin amounts imilar to 
that of the native artery. ~6 
The comparison between the graft and its corre- 
sponding artery, i.e. the artery it replaced, is sensible 
since there is an inter-individual difference in PGI2 
release. However, the numbers were small. With this 
comparison there was a difference in the unseeded 
group during perfusion periods four and five. The 
interpretation of this is not obvious, but it certainly 
suggests that the functional properties of unseeded 
grafts are inferior compared with their corresponding 
artery. 
Normally there is very low release of thromboxane 
from native arteries in the dog 8'13 and in the rabbit. 17 
This was the case also in sheep. Thromboxane r lease 
is not easily stimulated in arteries, 12 but there was a 
significantly higher release after addition of arachi- 
donic acid in both graft groups. This may depend on 
a mixed luminal cell population with different func- 
tional properties compared to native endothelium. 
Another possibility is that the diffusion through the 
healed graft wall was different from that of the artery. 
The assay has some cross-reactivity with arachidonic 
acid, but judged from the native artery group this is 
very low. There were no platelets left on the graft 
surface, which rules them out as the source of the 
measured thromboxane. 
A healthy artery is not comparable to a prosthesis, 
but in the artery, attempts have been made to identify 
the cells or cell layers responsible for production of 
PGI 2 and thromboxane. Moncada et al. is  found the 
highest rate of release of PGI2 from the intimal surface 
layers and a decrease towards the adventitial region. 
The release from the free-dissected intima was around 
37% of the total release from the arterial wall. 
Sinzinger et al. 19 studied punch biopsies and cell 
cultures and found, on the contrar)~ a higher percent- 
age from the non-endothelial l yers. Our own compar- 
ison of incubation vs. perfusion 7 shows that around 
44% of the total vessel wall PGI2 release comes from 
the luminal side. The corresponding figure for throm- 
boxane is 16%. 
The choice of species is important. 2° There is no 
ideal animal for thrombosis research. We choose the 
sheep on the basis of earlier experiments 1~'21 and 
because their coagulation parameters are, in some 
ways, similar to those of humans. 22 In order to 
evaluate the endothelial cell seeding process we 
deliberately did not use any platelet aggregation 
inhibitor, although there is evidence that this might be 
beneficial in combination with seeding. 1 Other experi- 
ments have suggested that contrary. 23There was no 
difference in patenc)~ but the numbers were too small 
to draw any conclusions in this respect, and moreover 
this was not he primary aim of this experiment. 
The morphological studies can, for practical rea- 
sons, only show a small sample of the total graft. 
Nevertheless they are helpful in the understanding of 
graft healing. From light microscopic criteria the 
endothelial cell coverage was patchy and scarce, and 
from SEM criteria it was more abundant. We could not 
find any correlation between the two methods. In 
contrast to our findings from the 3 week experiment, 11 
at which time it was fairly easy to categorise the SEM 
findings due to a more or less all-or-nothing cellular 
covering, the 3 months of healing resulted in a high 
degree of cellular coverage, although the cell identi- 
fication was not always easy. In humans vascular 
grafts heal with only limited ingrowth of endothe- 
lium, 24 so in this respect he sheep is a less accurate 
model of human characteristics. 
PGI 2 release is only one of several regulatory factors 
where the endothelium is involved, but this analysis is 
an attempt at a more functional view of the healing 
graft. When summing up the results from 3 weeks of 
implantation ~ and 3 months it is fair to say that after 
3 weeks the seeded grafts had a significantly higher 
PGI 2 release than the unseeded, but significantly 
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lower than that of the native artery. After 3 months no 
difference could be demonstrated between the native 
artery and the seeded graft, but the unseeded graft 
had a lower, possibly significant release. This suggests 
a functional difference, despite the long healing time. 
At 3 weeks, the seeded grafts had a better coverage, 
but at 3 months this had, in both types of grafts, 
evolved to a patchy coverage of endothelium and a 
population of fibroblasts. It thus seems that the 
seeding process encourages an early functional 
improvement, but it does not lead to a prolonged 
improvement which "stays ahead" of an unseeded 
graft. The possibility exists that other factors, such as 
a cascade of growth factors and the migration of 
fibroblasts induced by the surgical trauma or the graft 
itself, exert an influence which outweighs the possible 
benefits from the seeded cells. 
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